Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Capecitabine in Treating Patients With Malignant Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | November 1, 2000 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00004183 |
| Study Type: | Interventional |
| Intervention: | Drug: capecitabine |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Cancer and Leukemia Group B|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Other|NIH |
| First Received: | January 21, 2000 |
| End Date: | |
| Last Updated: | February 6, 2010 |
| Last Verified: | July 1, 2005 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
